PE20011270A1 - [5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1) - Google Patents

[5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1)

Info

Publication number
PE20011270A1
PE20011270A1 PE2001000376A PE2001000376A PE20011270A1 PE 20011270 A1 PE20011270 A1 PE 20011270A1 PE 2001000376 A PE2001000376 A PE 2001000376A PE 2001000376 A PE2001000376 A PE 2001000376A PE 20011270 A1 PE20011270 A1 PE 20011270A1
Authority
PE
Peru
Prior art keywords
quinolon
guanidine
carbonyl
cyclopropil
pirazol
Prior art date
Application number
PE2001000376A
Other languages
English (en)
Inventor
Angel Guzman-Perez
Eric David Cox
Weichao George Chen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20011270A1 publication Critical patent/PE20011270A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I [5-CICLOPROPIL-1-(2-QUINOLON-5-IL)-1H-PIRAZOL-4-CARBONIL]GUANIDINA CON LA CONDICION DE QUE EL COMPUESTO [5-CICLOPROPIL-1-(QUINOLON-5-IL)-1H-PIRAZOL-4-CARBONIL]GUANIDINA NO SE INCLUYA. LA DOSIS ES DE 0,01mg/kg/DIA A 50 mg/kg/DIA Y SE ADMINISTRA DE MODO PROFILACTICO, ANTES O DURANTE LA CIRUGIA Y EN LAS 24 HORAS SIGUIENTES A LA CIRUGIA. SE REFIERE TAMBIEN A UN COMPOSICION FARMACEUTICA. EL COMPUESTO DE FORMULA I ES UN INHIBIDOR DEL INTERCAMBIADOR DE SODIO-HIDROGENO TIPO 1 (NHE-1) Y ES UTIL PARA ES UTIL PARA REDUCIR LAS LESIONES TISULARES RESULTANTE DE LA ISQUEMIA O HIPOXIA EN DIFERENTES TEJIDOS
PE2001000376A 2000-04-28 2001-04-26 [5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1) PE20011270A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
PE20011270A1 true PE20011270A1 (es) 2001-12-12

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000376A PE20011270A1 (es) 2000-04-28 2001-04-26 [5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (es)
JP (1) JP2003531900A (es)
KR (1) KR20020093079A (es)
CN (1) CN1225466C (es)
AP (1) AP2002002651A0 (es)
AR (1) AR028375A1 (es)
AU (1) AU2001235896A1 (es)
BG (1) BG107139A (es)
BR (1) BR0110268A (es)
CA (1) CA2407535A1 (es)
CO (1) CO5221125A1 (es)
CR (1) CR6797A (es)
CZ (1) CZ20023408A3 (es)
DZ (1) DZ3310A1 (es)
EA (1) EA004882B1 (es)
EE (1) EE200200615A (es)
GT (1) GT200100064A (es)
HN (1) HN2001000042A (es)
HR (1) HRP20020851A2 (es)
HU (1) HUP0300651A2 (es)
IL (1) IL152075A0 (es)
IS (2) IS6567A (es)
MA (1) MA26897A1 (es)
MX (1) MXPA02010600A (es)
MY (1) MY133842A (es)
NO (1) NO20025132L (es)
NZ (1) NZ521348A (es)
OA (1) OA12256A (es)
PA (1) PA8513301A1 (es)
PE (1) PE20011270A1 (es)
PL (1) PL357765A1 (es)
SK (1) SK14872002A3 (es)
SV (1) SV2002000418A (es)
TN (1) TNSN01065A1 (es)
TR (1) TR200202439T2 (es)
UA (1) UA73348C2 (es)
UY (1) UY26680A1 (es)
WO (1) WO2001083470A1 (es)
YU (1) YU79602A (es)
ZA (1) ZA200208605B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL156220A0 (en) * 2001-01-31 2003-12-23 Pfizer Prod Inc Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
AU2002337460A1 (en) * 2001-12-19 2003-06-30 Pfizer Products Inc. Methods for preparing sodium-hydrogen exchanger type-1 inhibitors
CA2483927A1 (en) * 2002-05-02 2003-11-13 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
US7550480B2 (en) * 2003-02-14 2009-06-23 Smithkline Beecham Corporation Compounds
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA003603B1 (ru) * 1998-02-27 2003-06-26 Пфайзер Продактс Инк. N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии

Also Published As

Publication number Publication date
EA200201023A1 (ru) 2003-02-27
JP2003531900A (ja) 2003-10-28
TNSN01065A1 (fr) 2005-11-10
EP1276737A1 (en) 2003-01-22
EE200200615A (et) 2004-04-15
CN1426404A (zh) 2003-06-25
CO5221125A1 (es) 2002-11-28
KR20020093079A (ko) 2002-12-12
ZA200208605B (en) 2003-10-24
IS6567A (is) 2002-09-24
NO20025132L (no) 2002-12-12
NO20025132D0 (no) 2002-10-25
UY26680A1 (es) 2001-12-28
TR200202439T2 (tr) 2003-02-21
CN1225466C (zh) 2005-11-02
HRP20020851A2 (en) 2005-02-28
WO2001083470A1 (en) 2001-11-08
IS6588A (is) 2002-10-21
IL152075A0 (en) 2003-05-29
SV2002000418A (es) 2002-07-03
PA8513301A1 (es) 2003-09-05
HN2001000042A (es) 2001-07-09
AU2001235896A1 (en) 2001-11-12
MXPA02010600A (es) 2003-03-10
PL357765A1 (en) 2004-07-26
UA73348C2 (en) 2005-07-15
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
OA12256A (en) 2003-11-06
CA2407535A1 (en) 2001-11-08
BR0110268A (pt) 2003-12-30
AP2002002651A0 (en) 2002-12-31
NZ521348A (en) 2004-09-24
AR028375A1 (es) 2003-05-07
CZ20023408A3 (cs) 2004-01-14
HUP0300651A2 (hu) 2003-07-28
CR6797A (es) 2004-05-17
SK14872002A3 (sk) 2004-03-02
EA004882B1 (ru) 2004-08-26
DZ3310A1 (fr) 2001-11-07
BG107139A (bg) 2003-07-31
GT200100064A (es) 2002-03-22
MY133842A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
MXPA03005464A (es) Agentes antivirales.
IS8502A (is) Azatvíhringja heteróhringir sem kannabínóíð-viðtakastillar
CU23105A3 (es) DERIVADOS NOVEDOSOS DEL áCIDO AMINODICARBOXILICO CON PROPIEDADES FARMACéUTICAS
UY26977A1 (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgésicos
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
SE0202463D0 (sv) Novel compounds
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
BRPI0313942B8 (pt) derivados de benzimidazol úteis como agentes antiproliferativos, seus processos de preparação, composição farmacêutica compreendendo os mesmos e usos dos referidos compostos nas preparações de composições farmacêuticas
PA8591701A1 (es) Derivados de pirrolopirimidina
ECSP024393A (es) Derivados biciclicos sustituidos para el tratamiento del crecimiento celular normal
MY123310A (en) Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
AR058180A1 (es) Indeno derivados, su preparacion y su uso como medicamentos
CR7931A (es) 4-[(2,4-dicloro-5-metroxifenil)amino]-6-alkoxi-3- quinolincarbonitrilos para el tratamiento de lesiones isquemicas
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
AR036248A1 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
PE20010541A1 (es) Uso de una composicion de benzimidazol para tratar el cancer
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PE20011270A1 (es) [5-ciclopropil-1-(2-quinolon-5-il)-1h-pirazol-4-carbonil]guanidina como inhibidor del intercambiador de sodio-hidrogeno de tipo 1 (nhe-1)
UY30847A1 (es) Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales
AR038658A1 (es) Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
TR200102008T2 (tr) Serebral işemi profilaksı ve tedavisi için piridin türevlerinin kullanımı.
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
BRPI9509819B8 (pt) benzamida enterocinética e composição farmacêutica compreendendo a mesma
AR026022A1 (es) Metodo para el tratamiento de la obesidad

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed